Literature DB >> 30642936

Ceftolozane-Tazobactam Pharmacokinetics during Extracorporeal Membrane Oxygenation in a Lung Transplant Recipient.

Fabio Arena1, Luca Marchetti2, Lucia Henrici De Angelis3, Enivarco Maglioni2, Martina Contorni2, Maria Iris Cassetta4, Andrea Novelli4, Gian Maria Rossolini5,6.   

Abstract

Entities:  

Keywords:  Pseudomonas aeruginosa; multidrug resistance; pharmacokinetics; therapeutic drug monitoring; transplantation

Mesh：

Substances：

Year:  2019        PMID： 30642936      PMCID： PMC6395943          DOI： 10.1128/AAC.02131-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Real-world use of ceftolozane/tazobactam: a systematic literature review.

Authors:  Laura Puzniak; Ryan Dillon; Thomas Palmer; Hannah Collings; Ashley Enstone
Journal:  Antimicrob Resist Infect Control       Date:  2021-04-08       Impact factor: 4.887

Review 2.  Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis.

Authors:  Jaideep Vazirani; Thomas Crowhurst; C Orla Morrissey; Gregory I Snell
Journal:  Infect Drug Resist       Date:  2021-12-10       Impact factor: 4.003

3.  Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study.

Authors:  Camille Mané; Clément Delmas; Jean Porterie; Géraldine Jourdan; Patrick Verwaerde; Bertrand Marcheix; Didier Concordet; Bernard Georges; Stéphanie Ruiz; Peggy Gandia
Journal:  J Transl Med       Date:  2020-05-27       Impact factor: 5.531

Review 4.  Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management.

Authors:  Elena Xu; David Pérez-Torres; Paraskevi C Fragkou; Jean-Ralph Zahar; Despoina Koulenti
Journal:  Microorganisms       Date:  2021-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.